Literature DB >> 21664110

Non-susceptibility to tigecycline in enterococci from hospitalised patients, food products and community sources.

Ana R Freitas1, Carla Novais, Rosa Correia, Márcia Monteiro, Teresa M Coque, Luísa Peixe.   

Abstract

In this study, the in vitro activity of tigecycline against 1140 enterococci collected from humans, food products, animals and the environment in Portugal (1996-2008) was analysed. Ten isolates (seven Enterococcus faecalis and three Enterococcus spp.) non-susceptible to tigecycline (minimum inhibitory concentrations of 0.5-1.0 mg/L), which were also resistant to tetracycline and minocycline, were mostly observed in samples collected before the introduction of tigecycline in the therapeutic arsenal. The E. faecalis isolates were recovered from hospitalised patients (n=2; ST319/CC2 and ST34), healthy humans (n=2; ST21/CC21), chicken meat (n=1; ST260) as well as from two swine samples. The remaining isolates were also recovered from chicken meat (n=1; Enterococcus gallinarum) and swine (n=2; Enterococcus hirae and Enterococcus spp.). Recovery of enterococcal isolates with reduced susceptibility to tigecycline amongst different reservoirs, including animals for food consumption, suggests that selection of tigecycline-resistant isolates by antibiotics other than tigecycline might occur in non-clinical settings.
Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664110     DOI: 10.1016/j.ijantimicag.2011.04.014

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Enterococcal endocarditis: can we win the war?

Authors:  Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Rampant Parasexuality Evolves in a Hospital Pathogen during Antibiotic Selection.

Authors:  Kathryn Beabout; Troy G Hammerstrom; Tim T Wang; Minny Bhatty; Peter J Christie; Gerda Saxer; Yousif Shamoo
Journal:  Mol Biol Evol       Date:  2015-06-09       Impact factor: 16.240

3.  Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium.

Authors:  Vincent Cattoir; Christophe Isnard; Thibaud Cosquer; Arlène Odhiambo; Fiona Bucquet; François Guérin; Jean-Christophe Giard
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 4.  Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?

Authors:  Ana M Guzman Prieto; Willem van Schaik; Malbert R C Rogers; Teresa M Coque; Fernando Baquero; Jukka Corander; Rob J L Willems
Journal:  Front Microbiol       Date:  2016-05-26       Impact factor: 5.640

Review 5.  Enterococci, from Harmless Bacteria to a Pathogen.

Authors:  Sónia Ramos; Vanessa Silva; Maria de Lurdes Enes Dapkevicius; Gilberto Igrejas; Patrícia Poeta
Journal:  Microorganisms       Date:  2020-07-25

6.  Genotypic diversity, antibiotic resistance and bacteriocin production of enterococci isolated from rhizospheres.

Authors:  Naouel Klibi; Naouel Ben Slimen; Imen Fhoula; Maria López; Karim Ben Slama; Daniele Daffonchio; Abdellatif Boudabous; Carmen Torres; Hadda Ouzari
Journal:  Microbes Environ       Date:  2012-10-31       Impact factor: 2.912

7.  Role played by the environment in the emergence and spread of antimicrobial resistance (AMR) through the food chain.

Authors:  Konstantinos Koutsoumanis; Ana Allende; Avelino Álvarez-Ordóñez; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Lieve Herman; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Héctor Argüello; Thomas Berendonk; Lina Maria Cavaco; William Gaze; Heike Schmitt; Ed Topp; Beatriz Guerra; Ernesto Liébana; Pietro Stella; Luisa Peixe
Journal:  EFSA J       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.